Assertio (ASRT) Scheduled to Post Earnings on Monday

Assertio (NASDAQ:ASRT - Get Free Report) will be posting its quarterly earnings results after the market closes on Monday, May 6th. Analysts expect Assertio to post earnings of ($0.01) per share for the quarter. Persons interested in registering for the company's earnings conference call can do so using this link.

Assertio (NASDAQ:ASRT - Get Free Report) last issued its quarterly earnings data on Monday, March 11th. The company reported $0.08 EPS for the quarter. Assertio had a positive return on equity of 6.30% and a negative net margin of 218.28%. The firm had revenue of $32.99 million during the quarter, compared to analyst estimates of $31.42 million. On average, analysts expect Assertio to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Assertio Stock Performance

Shares of NASDAQ ASRT traded up $0.02 during mid-day trading on Monday, hitting $0.85. The stock had a trading volume of 786,754 shares, compared to its average volume of 1,034,304. The company has a debt-to-equity ratio of 0.28, a quick ratio of 1.43 and a current ratio of 1.83. The company has a 50 day moving average of $0.91 and a two-hundred day moving average of $1.15. Assertio has a twelve month low of $0.73 and a twelve month high of $8.01. The firm has a market cap of $80.66 million, a PE ratio of -0.21 and a beta of 0.96.

Assertio Company Profile

Assertio Holdings, Inc, a commercial pharmaceutical company, provides various products to patients in the United States. Its pharmaceutical products include INDOCIN, an oral and suppository solution for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing spondylitis and osteoarthritis; and acute painful shoulder and gouty arthritis.